Enteropathy-associated T-cell lymphoma (EATL) is defined as an intestinal lymphoma of intraepithelial T lymphocytes. EATL is further classified into two distinct types: type I (classical) EATL, which comprises 80%?90% of all cases; and type II EATL, a monomorphic variant of the disease. Type I EATL occurs at a higher frequency in northern Europe, where celiac disease is more common, and is characterized by the presence of large tumor cells with a CD3+CD4?CD8?CD56? immunophonotype. 1 Conversely, type II EATL, originally described as CD56+ intestinal lymphoma, consists of monomorphic small- to medium-sized tumor cells, typically with a CD3+CD4?CD8+CD56+ immunophenotype,
with weak or no association with celiac disease.1,2 Recently, a number of reports have defined type II EATL as a
distinct T-cell neoplasm predominant in patients of Asian ethnicity with no history of enteropathy or Epstein-Barr virus (EBV) association. In addition, type II EATL is characterized by frequent expression of gamma-delta T-cell receptors (γδ TCR).EBV-positive cases were suggested to represent extranodal natural killer (NK)/T-cell lymphoma rather than type II EATL. Whether EBV-positive cases with similar morphology and phenotype should be included in the definition of EATL and whether a proportion of these cases are γδ T-cell lymphomas remain debatable. Herein, we report a case of T-cell lymphoma of the jejunum with a CD3+ CD4?CD8+CD56?betaF1+ phenotype, rearranged γ TCR genes, and diffuse EBV-encoded RNA (EBER) positivity.
|